Position in LLY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,249,689,659
-$243,642,820 QoQ
Shares Held
1,358,698
-2.2% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $4,442,669,436 across 18 Drug Manufacturers - General names. LLY ranks #1 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,358,698 | $1,249,689,659 | |
| 2 | JNJ |
Johnson & Johnson
|
3,829,150 | $935,997,426 | |
| 3 | ABBV |
AbbVie Inc.
|
2,897,983 | $630,282,322 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,797,430 | $456,792,854 | |
| 5 | AMGN |
Amgen Inc
|
914,016 | $321,596,529 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,236,312 | $311,674,803 | |
| 7 | PFE |
Pfizer Inc
|
8,875,485 | $249,223,618 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,647,568 | $221,224,999 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,249,689,659 | 1,358,698 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,493,332,479 | 1,389,560 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,099,342,608 | 1,440,816 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,142,053,544 | 1,465,054 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,235,330,931 | 1,495,721 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,149,345,108 | 1,488,789 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,341,896,108 | 1,514,658 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,429,958,982 | 1,579,402 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,198,556,294 | 1,540,640 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $898,085,607 | 1,540,667 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $835,136,169 | 1,554,812 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $724,665,082 | 1,545,194 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $524,911,631 | 1,528,483 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $537,789,190 | 1,470,012 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $456,320,250 | 1,411,227 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $448,324,169 | 1,382,735 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $387,030,773 | 1,351,506 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $367,750,192 | 1,331,367 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $302,468,710 | 1,309,105 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $309,067,500 | 1,346,582 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $264,443,710 | 1,415,500 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $255,198,958 | 1,511,484 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $227,412,895 | 1,536,366 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $254,667,150 | 1,551,146 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $201,427,127 | 1,452,041 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||